Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Rhythm Pharmaceuticals Inc., 3 years.
Rhythm Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 21, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +3,000 | — | — |
| May 15, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −69 | $430.93 | $29,734 |
| Feb 26, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −5,034 | $425.70 | $2,142,974 |
| Feb 23, 2024 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −4,714 | $431.79 | $2,035,458 |
| Feb 21, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −3,603 | $421.77 | $1,519,637 |
| Feb 20, 2024 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −3,373 | $420.58 | $1,418,616 |
| Feb 20, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −4,804 | $420.79 | $2,021,475 |
| Feb 16, 2024 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −4,499 | $424.01 | $1,907,621 |
| Feb 12, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −4,295 | $420.24 | $1,804,931 |
| Feb 9, 2024 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −3,177 | $422.74 | $1,343,045 |
| Feb 7, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +8,448 | — | — |
| Feb 6, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +6,976 | — | — |
| Feb 6, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +11,210 | — | — |
| Dec 13, 2023 | Vertex Pharmaceuticals Incorporated | Option exercise | +8,603 | $187.53 | $1,613,321 |
| Dec 13, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −8,603 | $399.00 | $3,432,597 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.